CagriSema vs Exenatide
Overview
CagriSema and Exenatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares CagriSema and Exenatide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| CagriSema | Exenatide | |
|---|---|---|
| Category | Weight Management & Metabolic | Weight Management & Metabolic |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | Clinical trials | 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) |
| Frequency | weekly | Twice daily (Byetta) or once weekly (Bydureon) |
| Reported benefits | Superior weight loss results, metabolic optimization | Glycemic control (HbA1c reduction 0.8–1.9 percentage points), modest body weight reduction (2–4 kg), low intrinsic hypoglycemia risk, modest systolic blood pressure reduction, cardiovascular non-inferiority established in EXSCEL |
| Reported side effects | Under study | Nausea, vomiting, diarrhea, injection site reactions, hypoglycemia (when co-administered with sulfonylureas), rare acute pancreatitis, rare acute kidney injury |
Key differences
Primary use. CagriSema is categorised under Weight Management & Metabolic, while Exenatide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. CagriSema: not FDA-approved; treated as a research compound. Exenatide: FDA-approved.
Dosing. CagriSema is typically dosed at Clinical trials (weekly). Exenatide is typically dosed at 5–10 mcg (Byetta) or 2 mg (Bydureon/Bydureon BCise) (Twice daily (Byetta) or once weekly (Bydureon)).
Can you stack them?
Some protocols combine peptides, but stacking CagriSema and Exenatide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between CagriSema and Exenatide?
- CagriSema and Exenatide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. CagriSema is not FDA-approved; generally classified as a research compound, whereas Exenatide is FDA-approved for one or more indications.
- What is CagriSema used for?
- Combination therapy.
- What is Exenatide used for?
- FDA-approved GLP-1 receptor agonist for type 2 diabetes; the first incretin mimetic approved in the US.
- Can you take CagriSema and Exenatide together?
- Some users combine peptides within a single protocol, but stacking CagriSema and Exenatide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is CagriSema or Exenatide FDA-approved?
- CagriSema is not FDA-approved; generally classified as a research compound. Exenatide is FDA-approved for one or more indications.